The Value of Genomic Analysis of Breast Cancer in Drug Development

ISSN： 1052-6773

Source： Journal of the National Cancer Institute Monographs, Vol.2011, Iss.43, 2011-10, pp. : 60-62

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Integrative genomic analysis of interleukin36RN and its prognostic value in cancer

Molecular Medicine Reports, Vol. 13, Iss. 2, 2016-01 ,pp. : 1404-1412

Spandidos Publications

Access to resources Recommend Favorite

EORTC-IDBBC (Investigational Drug Branch for Breast Cancer): 5 Years of European Collaboration in New Drug Development for Breast Cancer

By EORTC-IDBBC Awada A. Van Vreckem A. Paridaens R. Bruning P.F. Klijn J. Tomiak E. Vinholes J. Roy J.A. Kusenda Z. Hoctin Boes G. Van Glabbeke M. Piccart M.J.

European Journal of Cancer, Vol. 33, Iss. 8, 1997-07 ,pp. : 1173-1176

Elsevier

Access to resources Recommend Favorite

Prognostic value of cyclin E expression in breast cancer: a meta-analysis

By Gao Sheng Ma Jing-Jing Lu Cheng

Tumor Biology, Vol. 34, Iss. 6, 2013-12 ,pp. : 3423-3430

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic value of osteopontin expression in breast cancer: A meta-analysis

Molecular and Clinical Oncology, Vol. 3, Iss. 2, 2015-01 ,pp. : 357-362

Science Publishers

Access to resources Recommend Favorite

Comparison of the prognostic value of genomic grade index, Ki67 expression and mitotic activity index in early node-positive breast cancer patients

By Bertucci F. Finetti P. Roche H. Le Doussal J. M. Marisa L. Martin A. L. Lacroix-Triki M. Blanc-Fournier C. Jacquemier J. Peyro-Saint-Paul H. Viens P. Sotiriou C. Birnbaum D. Penault-Llorca F.

Annals of Oncology, Vol. 24, Iss. 3, 2013-03 ,pp. : 625-632

Oxford University Press

Access to resources Recommend Favorite